Drug
Padsevonil clinical trials
Also written UCB0942.
- studies test it
- 14
- open now
- 0
- in phase 3
- 1
- first study started
- 2015
How studies write it
Studies that test it under each name
Name
- PSL
- 2
Development codes
Studies by the year they started
14 studies that test it; most in 2019 (7)
| Year | Studies |
|---|---|
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 7 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 4
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses padsevonil is read from its arms, and is right about nine times in ten.
Testing it · 14
- Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant EpilepsyCompletedPhase 2UCB Biopharma S.P.R.L.NCT03373383Written as Padsevonil
- A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant EpilepsyTerminatedPhase 3UCB Biopharma SRLNCT03739840Written as Padsevonil
- An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyTerminatedPhase 2UCB Biopharma SRLNCT02625090Written as UCB0942
- Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant EpilepsyTerminatedPhase 2UCB Biopharma SRLNCT03370120Written as Padsevonil
- A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic FunctionTerminatedPhase 1UCB Biopharma S.P.R.L.NCT04136444Written as Padsevonil
- Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of PadsevonilCompletedPhase 1UCB Biopharma S.P.R.L.NCT03480243Written as Padsevonil (UCB0942)
- A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study ParticipantsCompletedPhase 1UCB Biopharma S.P.R.L.NCT04075409Written as Padsevonil
- A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study ParticipantsCompletedPhase 1UCB Biopharma S.P.R.L.NCT04013191Written as Padsevonil
- A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female ParticipantsTerminatedPhase 1UCB Biopharma SRLNCT04131517Written as Padsevonil
- A Study to Test the Cardiac Effects of Padsevonil in Healthy Study ParticipantsTerminatedPhase 1UCB Biopharma S.P.R.L.NCT04126343Written as Padsevonil
- A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or CannabidiolTerminatedPhase 1UCB Biopharma S.P.R.L.NCT04039919Written as Padsevonil
- A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilCompletedPhase 1UCB Biopharma S.P.R.L.NCT03695094Written as Padsevonil
- A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyCompletedPhase 2UCB Biopharma S.P.R.L.NCT02495844Written as UCB0942
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian SubjectsCompletedPhase 1UCB Biopharma S.P.R.L.NCT03168984Written as UCB0942
Codes
What other systems call padsevonil · ClinicalTrials.gg INT001366
- MeSH (NLM) C000708857padsevonilConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0R1HN52K0NPADSEVONILConfirmed FDA, NLM, Wikidata
- Wikidata Q27237119padsevonilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166432PadsevonilOne source FDA
- DrugBank DB14977One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000708857 | padsevonil | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0R1HN52K0N | PADSEVONIL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27237119 | padsevonil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166432 | Padsevonil | One source FDA |
| DrugBank | DB14977 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.